Sepsis ImmunoScore
Commercial- Indications
- Sepsis
Company intelligence / Profile preview
Prenosis
Chicago, Illinois, United Statesprenosis.com ↗
- Ownership
- Private
- Employees
- ~36
- Development stage
- Commercial
01
Overview
Prenosis has developed the Sepsis ImmunoScore™, the first FDA De Novo authorized AI diagnostic for sepsis. This tool integrates biomarker and clinical data to diagnose sepsis and predict adverse outcomes within hospital settings. The company’s technology has demonstrated utility in real-time clinical workflows by providing actionable risk categories rather than simple alerts. The product was named a TIME Best Invention of 2024.
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Device (AI-powered diagnostic device)Software (Clinical decision support software)Diagnostic tool
- Industry
- Digital Health Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Roche Diagnostics (commercial distribution collaboration; integration with Roche navify® Algorithm Suite platform)
Beyond the preview
Go deeper on Prenosis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prenosis.